Abeona Therapeutics Inc (FRA:PCJ)
€ 6.3 0.45 (7.69%) Market Cap: 248.06 Mil Enterprise Value: 154.68 Mil PE Ratio: 0 PB Ratio: 3.47 GF Score: 41/100

Q3 2020 Abeona Therapeutics Inc Earnings Call Transcript

Nov 10, 2020 / 01:30PM GMT
Release Date Price: €7.5
Operator

Good morning, and welcome to Abeona Therapeutics Third Quarter 2020 Financial Results Call. (Operator Instructions)

I'll now introduce your host for today's conference Greg Gin, Vice President of Investor Relations at Abeona. Please go ahead.

Gregory Gin
Abeona Therapeutics Inc. - VP of IR

Thank you, Christie. Good morning, everyone. I'd like to welcome and thank you for joining us on Abeona Therapeutics Third Quarter 2020 Conference Call. Yesterday, after the close of U.S. financial markets, we issued a press release announcing the third quarter results. The press release is posted on our website at www.abeonatherapeutics.com.

On the call today with prepared remarks are Michael Amoroso, Chief Operating Officer of Abeona Therapeutics; and Ed Carr, Chief Accounting Officer. After the prepared remarks, we will host a Q&A session. We are also joined by Jay Bircher, Chief Technical Officer.

Before we start, I'll review our safe harbor statement. Remarks made

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot